Table 2.
AZD9412 (N = 61) | Placebo (N = 60) | Ratio of proportions (95% CI) AZD9412 vs Placebo | p‐value | |
---|---|---|---|---|
n (%) | n (%) | |||
Severe exacerbations Days 1 to 14 |
7 (11.5%) | 5 (8.3%) | 1.29 (0.43, 3.85) | .64 |
Severe exacerbations Days 1 to 30 |
8 (13.1%) | 6 (10.0%) | 1.25 (0.46, 3.41) | .66 |
Abbreviations: CI, confidence interval; N, number; vs, versus.